The accurate establishment of a ferrite transformation start temperature model is crucial to design a reasonable controlled rolling process and ensure uniform microstructure in aluminum bearing dual-phase steel.The me...The accurate establishment of a ferrite transformation start temperature model is crucial to design a reasonable controlled rolling process and ensure uniform microstructure in aluminum bearing dual-phase steel.The measurements of the expansion-temperature curves of aluminum bearing dual-phase steel under continuous cooling and isothermal conditions are presented,utilizing a dynamic transformation dilatometer experiment.Based on these expansion-temperature curves,the start temperature and incubation time of ferrite transformation were determined,elucidating the influence of process parameters on both the incubation time and the start temperature of ferrite transformation.By integrating metallurgical principles with measured incubation time of ferrite transformation,and considering the effects of temperature and strain,a fitting model for the variation in volume free energy during ferrite nucleation was derived.Building upon this foundation,a high-precision incubation time of ferrite transformation mathematical model for the experimental steel was established.To more accurately calculate the start temperature of ferrite transformation under continuous cooling conditions,the Scheil’s additivity rule was modified to account for the effects of deformation and cooling rate.The results indicate that the modification coefficient decreases with increasing the cooling rate and strain,thereby significantly improving the accuracy of calculating the starting temperature of ferrite transformation using the modified additivity rule.展开更多
聚焦PEP新教材Start to read板块教学,针对传统阅读启蒙课存在的思维培养不足、教学活动单一等问题,提出“问题·活动·评价”三位一体的教学新范式。通过构建层级化问题体系引导思维进阶,设计梯度式活动促进语篇理解,实施全程...聚焦PEP新教材Start to read板块教学,针对传统阅读启蒙课存在的思维培养不足、教学活动单一等问题,提出“问题·活动·评价”三位一体的教学新范式。通过构建层级化问题体系引导思维进阶,设计梯度式活动促进语篇理解,实施全程化评价保障学习效果。研究表明,该范式能有效提升学生阅读兴趣与综合语言能力,为小学英语阅读启蒙教学提供可复制、可推广的创新路径。展开更多
Multiple sclerosis(MS) is a chronic inflammatory condition of the central nervous system determined by a presumed autoimmune process mainly directed against myelin components but also involving axons and neurons. Acut...Multiple sclerosis(MS) is a chronic inflammatory condition of the central nervous system determined by a presumed autoimmune process mainly directed against myelin components but also involving axons and neurons. Acute demyelination shows as clinical relapses that may fully or partially resolve, while chronic demyelination and neuroaxonal injury lead to persistent and irreversible neurological symptoms, often progressing over time. Currently approved disease-modifying therapies are immunomodulatory or immunosuppressive drugs that significantly although variably reduce the frequency of attacks of the relapsing forms of the disease. However, they have limited efficacy in preventing the transition to the progressive phase of MS and are of no benefit after it has started. It is therefore likely that the potential advantage of a given treatment is condensed in a relatively limited window of opportunity for each patient, depending on individual characteristics and disease stage, most frequently but not necessarily in the early phase of the disease. In addition, a sizable proportion of patients with MS may have a very mild clinical course not requiring a disease-modifying therapy. Finally, individual response to existing therapies for MS varies significantly across subjects and the risk of serious adverse events remains an issue, particularly for the newest agents. The present review is aimed at critically describing current treatment strategies for MS with a particular focus on the decision of starting, switching and stopping commercially available immunomodulatory and immunosuppressive therapies.展开更多
基金supported by the National Science and Technology Major Project-Intelligent Manufacturing Systems And Robots(2025ZD1602200)the National Key Research and Development Program of China(Grant No.2022YFB3304800).
文摘The accurate establishment of a ferrite transformation start temperature model is crucial to design a reasonable controlled rolling process and ensure uniform microstructure in aluminum bearing dual-phase steel.The measurements of the expansion-temperature curves of aluminum bearing dual-phase steel under continuous cooling and isothermal conditions are presented,utilizing a dynamic transformation dilatometer experiment.Based on these expansion-temperature curves,the start temperature and incubation time of ferrite transformation were determined,elucidating the influence of process parameters on both the incubation time and the start temperature of ferrite transformation.By integrating metallurgical principles with measured incubation time of ferrite transformation,and considering the effects of temperature and strain,a fitting model for the variation in volume free energy during ferrite nucleation was derived.Building upon this foundation,a high-precision incubation time of ferrite transformation mathematical model for the experimental steel was established.To more accurately calculate the start temperature of ferrite transformation under continuous cooling conditions,the Scheil’s additivity rule was modified to account for the effects of deformation and cooling rate.The results indicate that the modification coefficient decreases with increasing the cooling rate and strain,thereby significantly improving the accuracy of calculating the starting temperature of ferrite transformation using the modified additivity rule.
文摘聚焦PEP新教材Start to read板块教学,针对传统阅读启蒙课存在的思维培养不足、教学活动单一等问题,提出“问题·活动·评价”三位一体的教学新范式。通过构建层级化问题体系引导思维进阶,设计梯度式活动促进语篇理解,实施全程化评价保障学习效果。研究表明,该范式能有效提升学生阅读兴趣与综合语言能力,为小学英语阅读启蒙教学提供可复制、可推广的创新路径。
文摘Multiple sclerosis(MS) is a chronic inflammatory condition of the central nervous system determined by a presumed autoimmune process mainly directed against myelin components but also involving axons and neurons. Acute demyelination shows as clinical relapses that may fully or partially resolve, while chronic demyelination and neuroaxonal injury lead to persistent and irreversible neurological symptoms, often progressing over time. Currently approved disease-modifying therapies are immunomodulatory or immunosuppressive drugs that significantly although variably reduce the frequency of attacks of the relapsing forms of the disease. However, they have limited efficacy in preventing the transition to the progressive phase of MS and are of no benefit after it has started. It is therefore likely that the potential advantage of a given treatment is condensed in a relatively limited window of opportunity for each patient, depending on individual characteristics and disease stage, most frequently but not necessarily in the early phase of the disease. In addition, a sizable proportion of patients with MS may have a very mild clinical course not requiring a disease-modifying therapy. Finally, individual response to existing therapies for MS varies significantly across subjects and the risk of serious adverse events remains an issue, particularly for the newest agents. The present review is aimed at critically describing current treatment strategies for MS with a particular focus on the decision of starting, switching and stopping commercially available immunomodulatory and immunosuppressive therapies.
